Thông tin sản phẩm

Thông tin sản phẩm

Reusable and simple purification kit for preparing sequence-ready DNA:
– Complete elimination of “Dye Blobs” for high quality Phred scores and long read lengths.
– Flexible 6-20 µl elution volumes allow for direct loading of samples with no precipitation or drying steps.
– Reusable!

Clean-up PCR and other enzymatic reactions in as little as 2 minutes:
– Clean and concentrate up to 5 μg DNA with ≥ 6 μl elution in as little as 2 minutes with 0 μl wash residue carryover.
– Column design allows DNA to be eluted at high concentrations into minimal volumes of water or TE buffer.
– Eluted DNA is well suited for use in PCR, DNA sequencing, DNA ligation, endonuclease digestion, RNA transcription, radiolabeling, arrays, etc.

Clean-up PCR and other enzymatic reactions in as little as 2 minutes:
– Clean and concentrate up to 5 μg DNA with ≥ 6 μl elution in as little as 2 minutes with 0 μl wash residue carryover.
– Column design allows DNA to be eluted at high concentrations into minimal volumes of water or TE buffer.
– Eluted DNA is well suited for use in PCR, DNA sequencing, DNA ligation, endonuclease digestion, RNA transcription, radiolabeling, arrays, etc.

Easily isolate DNA from tough-to-lyse fungi and bacteria:
– Simple, efficient isolation of DNA from all types of tough-to-lyse fungi and bacteria in minutes.
– Ultra-high density BashingBeads™ are fracture resistant and chemically insert.

GeneProof Hepatitis C Virus (HCV) PCR Kit applies PCR technology to detect RNA of HCV virus in patient samples. The kit has CE-IVD certification for in vitro Diagnostic Use.

GeneProof Hepatitis B Virus (HBV) PCR Kit applies PCR technology to detect DNA of HBV virus in patient samples. The kit has CE-IVD certification for in vitro Diagnostic Use.

TruSight Exome Library Preparation Kit includes reagent sets for library preparation combined with exome enrichment to sequence genes on Next Generation Sequencing System of Illumina

TruSight Tumor 170 Kit includes library preparation reagent set and uses next-generation sequencing (NGS) technology to provide a comprehensive assessment of 170 genes that are commonly related to mutations in solid tumors and somatic variants.